10
Actividad in vitro de Ampicilina más Ceftriaxona Frente a e. Gallynarum, e. Durans y e. Casseliflavus Aislados en Pacientes con Endocarditis
J. García-González, C. García-de-la-Mària, M.A. Cañas, E. Rubio, M. Hernández-Meneses, J. Ambrosioni, B. Vidal, E. Sandoval, A. Moreno, J.M. Miró
Hospital Clínic-IDIBAPS. Universidad de Barcelona
Leído
2228
Vecesse ha leído el artículo
505
Total PDF
1723
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 25 | 11 | 36 |
| 2025 11 | 56 | 48 | 104 |
| 2025 10 | 54 | 19 | 73 |
| 2025 9 | 59 | 26 | 85 |
| 2025 8 | 59 | 23 | 82 |
| 2025 7 | 59 | 20 | 79 |
| 2025 6 | 78 | 13 | 91 |
| 2025 5 | 80 | 10 | 90 |
| 2025 4 | 78 | 13 | 91 |
| 2025 3 | 99 | 13 | 112 |
| 2025 2 | 62 | 13 | 75 |
| 2025 1 | 78 | 10 | 88 |
| 2024 12 | 78 | 8 | 86 |
| 2024 11 | 90 | 16 | 106 |
| 2024 10 | 78 | 7 | 85 |
| 2024 9 | 86 | 18 | 104 |
| 2024 8 | 39 | 12 | 51 |
| 2024 7 | 38 | 12 | 50 |
| 2024 6 | 30 | 13 | 43 |
| 2024 5 | 27 | 14 | 41 |
| 2024 4 | 34 | 7 | 41 |
| 2024 3 | 33 | 5 | 38 |
| 2024 2 | 19 | 11 | 30 |
| 2024 1 | 13 | 1 | 14 |
| 2023 12 | 12 | 14 | 26 |
| 2023 11 | 11 | 21 | 32 |
| 2023 10 | 17 | 13 | 30 |
| 2023 9 | 13 | 3 | 16 |
| 2023 8 | 23 | 12 | 35 |
| 2023 7 | 13 | 9 | 22 |
| 2023 6 | 33 | 6 | 39 |
| 2023 5 | 41 | 3 | 44 |
| 2023 4 | 25 | 3 | 28 |
| 2023 3 | 21 | 6 | 27 |
| 2023 2 | 25 | 5 | 30 |
| 2022 1 | 6 | 5 | 11 |
| 2022 12 | 7 | 4 | 11 |
| 2022 11 | 31 | 4 | 35 |
| 2022 10 | 17 | 3 | 20 |
| 2022 9 | 13 | 25 | 38 |
| 2022 8 | 31 | 21 | 52 |
| 2022 7 | 32 | 5 | 37 |
Mostrar todo
